Waters Corporation
Waters Corporation Reports Strong 2025 Financial Results and Provides 2026 Outlook
Summary
Waters Corporation announced its financial results for Q4 and full-year 2025, reporting strong growth in sales and earnings. The company's total sales for the full year increased by 7% to $3,165 million, and non-GAAP earnings per share (EPS) grew to $13.13. The company also provided guidance for 2026, expecting organic constant currency revenue growth in the range of 5.5% to 7.0%, with full-year non-GAAP EPS projected to be between $14.30 and $14.50. The positive financial performance was driven by growth in all end-markets and across all geographic regions.
Profitelligence Alerts
Get alerts for WAT
Be first to know when Waters Corporation files with the SEC.
Filing Categories
Advertisement
About Waters Corporation
Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
Official SEC Documents
Advertisement